About Ordesa
Ordesa is a Government & Social Sector company based in Barcelona (Spain) founded in 1943, and was acquired by Sodeinn in January 2021. Foundation focused on improvement of the living conditions, nutrition and health of the child population. Ordesa has completed 3 acquisitions, including Colnatur, FontActiv and Sodeinn. Ordesa offers products and services including Infant Nutrition Products and Adult Supplements. Its focus areas include Healthcare and Healthcare Foundations. Its legal entity is Laboratorios Ordesa.
Company details
Ordesa was established in 1943 in Barcelona, Spain, as a foundation dedicated to child welfare. Efforts are directed toward enhancing nutrition, health, and overall living conditions for the child population. Operations include research and programs in pediatric nutrition and health initiatives. The foundations activities are primarily conducted in Spain, with a focus on supporting local communities through evidence-based interventions.
- Headquarters Barcelona, Spain
- Stage Acquired
- SectorsGovernment & Social Sector
- Phone•••• ••••
- Website ordesalab.com
- Social LinkedIn
- Acquired by Sodeinn (Jan 2021)
- Legal Name Laboratorios Ordesa
- Latest Funding Round$16.86K (USD), Grant
Apr 2015
- InvestorsEuropean Union
& 1 more
- Investments & AcquisitionsColnatur
& 2 more
- Acquired bySodeinn
(Jan 2021)
Products & Services of Ordesa
Ordesa offers a comprehensive portfolio of products and services, including Infant Nutrition Products and Adult Supplements.
Products for infant feeding are developed and distributed by Ordesa to support health needs.
Dietary supplements for adults are offered by Ordesa to address nutritional requirements.
Funding Insights of Ordesa
- Total Rounds 1
- Last Round Grant — $16,863
- First Round $16,863
(Apr 2015)
- Investors Count 1
All 1 funding rounds of Ordesa with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2015 | $16,863 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Ordesa
Ordesa has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Sodeinn.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Provider of dietary food supplements for multiple ailments | 2013 | sodeinn.com | Madrid, Spain |
Investor details for Ordesa
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ordesa
Ordesa has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Colnatur, FontActiv and Sodeinn.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of nutritional supplements and probiotic drinks | fontactiv.com | Barcelona, Spain | 2013 | Dec 2023 | •••• | |
Provider of dietary food supplements for multiple ailments | sodeinn.com | Madrid, Spain | 2013 | Jul 2021 | •••• | |
Natural hydrolyzed collagen is manufactured by Colnatur in Spain. | colnatur.com | Barcelona, Spain | 2009 | May 2018 | •••• |
Complete acquisition details for Ordesa
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Ordesa
Web traffic of Ordesa
The website of Ordesa (ordesalab.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▼ 41% vs previous month
Websites whose visitors overlap most with Ordesa. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
balcondelpirineo.com | balcondelpirineo.com | 100% | #6,869,470 | – | |
ordesa.net | ordesa.net | 94% | #3,018,190 | – | |
ordesa.es | ordesa.es | 88% | #10,446,026 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ordesa
Complete news archive for Ordesa
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ordesa
Ordesa was founded in 1943 and raised its 1st funding round 72 years after it was founded.
Ordesa is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Ordesa was established in 1943 in Barcelona, Spain, as a foundation dedicated to child welfare. Efforts are directed toward enhancing nutrition, health, and overall living conditions for the child population. Operations include research and programs in pediatric nutrition and health initiatives. The foundations activities are primarily conducted in Spain, with a focus on supporting local communities through evidence-based interventions.
Ordesa offers Infant Nutrition Products and Adult Supplements.
Ordesa has 2 investors. Key investors include European Union, and Sodeinn.
Ordesa operates through Laboratorios Ordesa.
Yes. Ordesa was acquired by Sodeinn in January 2021.